Software Healthcare Sector

Jade Biosciences

Market Cap: US$1.5b

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Maze Therapeutics

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States.

Alphatec Holdings

Market Cap: US$1.5b

A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.

Maravai LifeSciences Holdings

Market Cap: US$1.5b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Harrow

Market Cap: US$1.5b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

Tyra Biosciences

Market Cap: US$1.5b

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

agilon health

Market Cap: US$1.5b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

CONMED

Market Cap: US$1.5b

A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Omada Health

Market Cap: US$1.5b

Together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.

PYC Therapeutics

Market Cap: AU$2.1b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Azenta

Market Cap: US$1.5b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Enovis

Market Cap: US$1.5b

A medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally.

ArriVent BioPharma

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Alvotech

Market Cap: US$1.4b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

InnovAge Holding

Market Cap: US$1.4b

Manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.

Inhibrx Biosciences

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Replimune Group

Market Cap: US$1.4b

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.

ORIC Pharmaceuticals

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.

Integra LifeSciences Holdings

Market Cap: US$1.4b

Manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

MoonLake Immunotherapeutics

Market Cap: US$1.4b

A clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Artivion

Market Cap: US$1.4b

Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Phibro Animal Health

Market Cap: US$1.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

Schrödinger

Market Cap: US$1.4b

Develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.

Vor Biopharma

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases.

Pennant Group

Market Cap: US$1.3b

Provides healthcare services in the United States.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Novavax

Market Cap: US$1.3b

A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.

Savara

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States.

Alpha Tau Medical

Market Cap: US$1.3b

A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

AMN Healthcare Services

Market Cap: US$1.3b

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Aktis Oncology

Market Cap: US$1.3b

A clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers.

Monte Rosa Therapeutics

Market Cap: US$1.3b

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Regis Healthcare

Market Cap: AU$1.9b

Engages in the provision of residential aged care services in Australia.

Immatics

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

Heska

Market Cap: US$1.3b

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.